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siRNA-Mediated RNA Interference in Precision-Cut Tissue Slices Prepared
from Mouse Lung and Kidney
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Abstract. Small interfering RNA (siRNA)-mediated RNAi interference (RNAi) is a powerful
post-transcriptional gene silencing mechanism which can be used to study the function of genes
in vitro (cell cultures) and in vivo (animal models). However, there is a translational gap between
these models. Hence, there is a need for novel experimental models that combine the advantages
of in vitro and in vivomodels (e.g., simplicity, ﬂexibility, throughput, and representability) to study
the effects of siRNA. This need may be addressed by precision-cut tissue slices (PCTS), which
represent an ex vivo model that mimics the structural and functional characteristics of a whole
organ. The goal of this study was to investigate whether self-deliverable siRNA (Accell siRNA)
can be used in precision-cut lung slices (PCLuS) and precision-cut kidney slices (PCKS) to achieve
RNAi ex vivo. PCLuS and PCKS were prepared from mouse tissue, and they were subsequently
incubated up to 48 h with no siRNA (untransfected), non-targeting Accell siRNA, or Gapdh-
targeting Accell siRNA. SigniﬁcantGapdhmRNA silencing was achieved (PCLuS ~ 55%; PCKS
~ 40%) without compromising the viability and morphology of slices. Fluorescence microscopy
conﬁrmed that Accell siRNA diffused into PCLuS and PCKS. Spontaneous inﬂammation upon
incubation was observed in PCLuS and PCKS as shown by a higher mRNA expression of pro-
inﬂammatory cytokines Il1b, Il6, and Tnfa, although Accell siRNA appeared to diminish this
response in PCLuS after 24 h. In conclusion, this ex vivo transfectionmodel can be used to evaluate
the effects of siRNA in relevant biological environments.
KEY WORDS: ex vivo; gene silencing; siRNA; tissue slices; transfection.
INTRODUCTION
Small interfering RNA (siRNA)-mediated RNA inter-
ference (RNAi) leads to the degradation of speciﬁc
messenger RNA (mRNA), thereby limiting the production
of a speciﬁc protein [1]. To that end, siRNA can be used, for
instance, to decrease the expression of disease-related genes,
to investigate the function of proteins, or to establish
experimental models of disease. Therefore, the use of siRNA
to induce RNAi in vitro (cell cultures) and in vivo (animal
models) has been described in various publications [2–4].
However, there is a big translational gap between in vitro and
in vivo models. In vitro models are known for their simplicity,
ﬂexibility, and high throughput but they lack a biological
context. Conversely, in vivo models generate more biologi-
cally relevant data although they are more complex to use.
Hence, there is an obvious need for novel experimental
models that combine the advantages of in vitro and in vivo
models to study the effects of siRNA.
This need may be addressed by using precision-cut tissue
slices (PCTS). PCTS refer to viable explants, with a well-
deﬁned thickness and diameter, prepared from tissue (e.g.,
lung and kidney) that can be cultured ex vivo [5, 6]. In
comparison to conventional in vitro models, PCTS offer
crucial advantages. Firstly, PCTS comprise the structural
and functional heterogeneity of tissues, including cell-matrix
interactions and intercellular interactions. Moreover,
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interspecies comparisons regarding biological effects of
siRNA are possible as PCTS can be prepared from animal
and human tissue. PCTS can also be quickly prepared in a
simple and reproducible manner with specialized equipment
that maintains the viability of tissue during the slicing process.
In addition, several experiments can be performed per animal
as multiple PCTS can be prepared from a single piece of
tissue. Lastly, PCTS can be incubated for up to 48–120 h,
depending on the tissue type and species, which means they
can be used to study endogenous metabolism, drug effects,
and disease mechanisms [5, 7–9]. As such, PCTS appear to
have potential as a novel experimental model to study the
effects of siRNA.
Nevertheless, RNAi in PCTS requires the successful
delivery of siRNA into the cytoplasm of cells. Because siRNA
is negatively charged and does not readily pass cell mem-
branes, researchers often use cationic nanocomplexes (e.g.,
polyplexes, lipoplexes, or lipopolyplexes) to achieve RNAi
in vitro and in vivo [10]. Unfortunately, such nanocomplexes
have a limited penetration into PCTS which appears to be
dependent on particle size and electrostatic interactions
between the particle and surrounding proteins; this could
lead to aggregation of nanocomplexes [11,12]. To overcome
this obstacle, self-deliverable siRNA could be used. Self-
deliverable siRNA, which refers to siRNA conjugated with
cell-penetrating peptides or sterols, requires no complexation
with polymers or lipids to enable transport into cells [13]. The
extent of diffusion through biological tissues is thought to be
greater for self-deliverable siRNA as it is smaller than
conventional nanocomplexes. Some publications have de-
scribed the successful induction of RNAi in vivo upon
administration of self-deliverable siRNA [14, 15]. Accord-
ingly, PCTS could be an ideal model to timely assess effects of
self-deliverable siRNA in both animal and human tissue.
Thus, the principal aim of this study was to investigate
whether self-deliverable siRNA (Accell siRNA) can success-
fully silence mRNA expression in precision-cut lung slices
(PCLuS) and precision-cut kidney slices (PCKS) prepared
from mouse tissue. These organs were selected as PCLuS and
PCKS represent non-solid and solid tissue. First, ﬂuorescence
microscopy and real-time quantitative polymerase chain
reaction (qPCR) was used to assess the diffusion of Accell
siRNA into slices and to determine whether RNAi was
successfully induced, respectively. Next, we analyzed the
adenosine triphosphate (ATP) content and morphology of
slices to determine whether slices remained viable during
transfections. Lastly, we studied the mRNA expression proﬁle
of pro-inﬂammatory cytokines (i.e., Il1b, Il6, and Tnfa) to
determine whether spontaneous inﬂammation develops upon
incubation and whether Accell siRNA can affect this (foreign




Tissue was obtained from C57BL/6J mice, which were
housed under controlled conditions with a 12-hour light/dark
cycle and free access to water and food (Central Animal
Facility, University Medical Center Groningen, Groningen,
The Netherlands). The lungs and kidneys were extracted in a
terminal procedure conducted under isoﬂurane/O2 anesthesia
(Nicholas Piramal, London, UK). Note, prior to being
extracted, the lungs were inﬂated in situ with liqueﬁed and
pre-warmed (37°C) support medium containing 1.5% low-
gelling-temperature agarose type VII (Sigma-Aldrich,
Zwijndrecht, The Netherlands) and 0.9% NaCl (Merck,
Darmstadt, Germany) to provide cutting support during the
slicing process [5]. After extraction, organs were immediately
placed in ice-cold University of Wisconsin (UW) preservation
solution (DuPont Critical Care, Waukegab, USA). All
experiments were approved by the Animal Ethical Commit-
tee of the University of Groningen (permit no. 6416AA).
Preparation of Slices
After the organ extraction, slices were prepared with a
Krumdieck tissue slicer (Alabama Research and Develop-
ment, Munford, USA), which was ﬁlled with ice-cold Krebs-
Henseleit buffer (KHB) supplemented with 25 mM D-glucose
(Merck), 25 mM NaHCO3 (Merck), and 10 mM HEPES (MP
Biomedicals, Aurora, USA); saturated with carbogen (95%
O2 and 5% CO2); and adjusted to a pH of 7.4 [5]. To prevent
loss of viability, slices were immediately transferred to ice-
cold UW preservation solution after slicing. PCLuS and
PCKS had a wet weight of 5–6 and 4–5 mg, respectively, with
an estimated thickness of 250–350 μm and a diameter of
~ 5 mm.
Incubation of Slices
Slices were incubated individually in a 1-mL pre-warmed
and oxygenated culture medium at 37°C under 5% CO2 and
80% O2, while gently shaken (90 cycles per minute). PCLuS
culture medium was composed of Accell siRNA Delivery
Media (GE Dharmacon, Lafayette, USA) supplemented with
100 U/mL penicillin-streptomycin (Life Technologies,
Bleiswijk, The Netherlands), 50 μg/mL gentamicin (Life
Technologies), and 0.1 mM non-essential amino acids (Life
Technologies). PCKS culture medium was composed of
Accell siRNA Delivery Media (GE Dharmacon) supple-
mented with 10 μg/mL ciproﬂoxacin (Fresenius Kabi, Zeist,
The Netherlands), and 10 mM glucose (Sigma-Aldrich).
Transfection of Slices
After the slicing procedure, slices were either directly
sampled or pre-incubated for 2 h in culture medium, as
described in the previous section. Slices were subsequently
transferred to the 1-mL pre-warmed and oxygenated culture
medium supplemented with 10 μL Accell siRNA buffer (GE
Dharmacon), ﬂuorescent red non-targeting Accell siRNA
(GE Dharmacon), non-targeting Accell siRNA pool (GE
Dharmacon), or Gapdh-targeting Accell siRNA pool (mouse)
(GE Dharmacon). Accell siRNA buffer contained 60 mM
KCl, 6 mM HEPES (pH 7.5), and 0.2 mM MgCl2. Gapdh-
targeting Accell siRNA was used to study speciﬁc mRNA
silencing while non-targeting Accell siRNA was used to
identify potential off-target effects. PCLuS culture medium
contained 0 or 0.5 μM siRNA, whereas PCKS culture
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medium contained 0 or 1.0 μM siRNA. After 24 or 48 h of
incubation, slices were collected for analysis.
Fluorescence
Confocal laser scanning microscopy was used to assess the
diffusion of red ﬂuorescent non-targeting Accell siRNA into
slices. Upon sampling, slices were brieﬂywashed (~ 5 s) in ice-cold
phosphate-buffered saline (PBS), embedded in KP-
CryoCompound (Klinipath, Duiven, The Netherlands), and
stored at − 80°C until use. Cross sections of 4 μm were prepared
from the slices by using a cryostat at − 20°C. The sections were
afterwards dried for 30 min at room temperature in the dark.
Thereafter, ProLong Diamond Antifade Mountant with DAPI
(Fisher Scientiﬁc, Landsmeer, The Netherlands) was applied to
the sections, which were subsequently covered with glass
coverslips. The sections were then dried for 24 h at room
temperature in the dark. Sections were stored at room tempera-
ture in the dark until further use. Images were taken with a Leica
TCS SP8 confocal microscope (Leica Microsystems, Rijswijk,
The Netherlands). Imaging of DAPI and red ﬂuorescent non-
targeting Accell siRNA (DY-547) was done through excitation
using laser lines at wavelengths of 405 and 552 nm, respectively.
mRNA Expression
Silencing and inﬂammatory effects of Accell siRNA on
mRNAexpressionwere determined by qPCR.After transfection,
three slices of the same condition were pooled, snap-frozen in
liquid nitrogen, and stored at − 80°C until further use. As column-
based RNA isolation procedures are incompatible with agarose-
containing slices, total RNA of PCLuS was extracted using the
Maxwell 16 LEV SimplyRNA Tissue Kit (Promega, Leiden,
The Netherlands), whereas total RNA of PCKS was isolated with
the FavorPrep Tissue Total RNA Mini Kit (Bio-Connect,
Huissen, The Netherlands) [17]. Isolated RNA (750 ng) was
reverse transcribed with the Reverse Transcription System
(Promega), using an Eppendorf mastercycler (25°C for 10 min,
45°C for 60min, and 95°C for 5min). Next, themRNAexpression
was analyzed by qPCR, using speciﬁc primers (Table I) and
FastStart Universal SYBR Green Master (Roche, Almere,
The Netherlands). The qPCR analysis was carried out with a
ViiA7 real-time qPCR (Applied Biosystems, Bleiswijk,
The Netherlands), using 1 cycle of 10 min at 95°C and 40 cycles
of 15 s at 95°C, 30 s at 60 C, and 30 s at 72 C. Finally, mRNA
expression was calculated as fold induction with the 2−ΔΔCt
method, using 18s as reference gene.
ATP Content
The ATP content in slices was quantiﬁed to determine
whether Accell siRNA affected the viability. After transfec-
tion, slices were placed individually in tubes containing 1 mL
of sonication solution (70% ethanol and 2 mM EDTA). The
samples were subsequently snap-frozen in liquid nitrogen and
stored at − 80°C until use. Next, the ATP content was
analyzed with the ATP Bioluminescence Kit (Roche Diag-
nostics, Mannheim, Germany), as described previously [5].
Obtained ATP values (pmol) were normalized with respect to
the total amount of protein (μg) which was determined with
the RC DC Protein Assay (Bio Rad).
Morphology
Morphological analyses were performed to assess whether
Accell siRNA affected the structural integrity of the slices. After
the transfection, slices were ﬁxed in 4% formalin at 4°C for 24 h.
Next, slices were dehydrated in ethanol baths with increasing
concentrations. Slices were subsequently cleared in xylene baths.
Thereafter, slices were horizontally embedded in parafﬁn and
sectioned (4 μm). Prior to staining with hematoxylin and eosin
(H&E), sections were deparafﬁnized and rehydrated. The
microscopic appearance of slices was assessed by evaluating the
cytoplasm and the shape/staining of nuclei. Sections were
scanned with a C9600 NanoZoomer (Hamamatsu Photonics,
Hamamatsu City, Japan).
Statistics
Statistics were performed with GraphPad Prism 6.0 using
one-way analyses of variance (ANOVA) followed by post hoc
Tukey’s multiple comparisons tests. Differences between
groups were considered to be statistically signiﬁcant when
p < .05. Note, qPCR data was analyzed statistically by using
the ΔCt values, although the data is shown as fold induction
(2−ΔΔCt).
RESULTS
siRNA Penetration into PCTS
Confocal laser scanning microscopy was used to conﬁrm
whether Accell siRNA penetrates into PCLuS and PCKS after
48 h of incubation (Fig. 1). Nuclei were stained with DAPI (blue)
and showed a staining pattern consistent with morphology data
(i.e., apoptotic regions at proximal tubules in PCKS). More
importantly, ﬂuorescent non-targeting Accell siRNA (red) was
able to diffuse into PCLuS and PCKS, though the extent of
diffusion was greater in PCLuS than in PCKS.
siRNA-Mediated RNAi in PCTS
qPCR analyses were performed to determine whether
siRNA-mediated RNAi occurred in PCLuS and PCKS after
being incubated with no siRNA (untransfected), non-
targeting Accell siRNA, or Gapdh-targeting Accell siRNA
Table I. Primer Details
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for 48 h (Fig. 2). In PCLuS and PCKS, Gapdh-targeting
Accell siRNA signiﬁcantly lowered Gapdh mRNA expression
by ~ 55 and ~ 40%, respectively, compared to untransfected
slices. Furthermore, non-targeting Accell siRNA did not
signiﬁcantly change Gapdh mRNA expression in PCLuS
and PCKS.
ATP Content During siRNA Transfections
The ATP content in PCLuS and PCKS was quantiﬁed to
check whether Accell siRNA could negatively affect the
viability after culturing slices up to 48 h (Fig. 3). No
signiﬁcant changes were observed in ATP content between
Fig. 1. siRNA penetration into PCTS. Slices were untransfected (a PCLuS, b PCKS) or treated
with non-targeting Accell siRNA (c PCLuS, d PCKS) or ﬂuorescent red non-targeting Accell
siRNA (e PCLuS, f PCKS) for 48 h (n = 4). Slices were subsequently collected for analysis by
confocal laser scanning microscopy. Cross sections (4 μm) were prepared with a cryostat and
mounted with ProLong Diamond Antifade Mountant with DAPI (blue). Representative images
(magniﬁcation 20×) are shown of independent experiments performed in triplicate
Fig. 2. siRNA-mediated RNAi in PCTS. a PCLuS and b PCKS were untransfected or treated with non-
targeting Accell siRNA or Gapdh-targeting Accell siRNA for 48 h (n = 4). Thereafter, Gapdh mRNA
expression was analyzed by qPCR. 18s was used as reference gene. Values represent individual experiments
performed in triplicate and are accompanied with the arithmetic mean (horizontal line) ± standard error of
the mean (error bars). Differences were statistically signiﬁcant when p < .05 (one-way ANOVA, post hoc
Tukey’s multiple comparisons test)
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PCLuS and PCKS treated with no siRNA, non-targeting
Accell siRNA, and Gapdh-targeting Accell siRNA.
Morphology After siRNA Transfections
The morphology of PCLuS and PCKS was evaluated to
identify whether Accell siRNA affected the structural integ-
rity of slices after 48 h of incubation (Fig. 4). As shown,
PCLuS maintained their structural integrity. No substantial
differences were observed between untransfected slices and
slices treated with non-targeting Accell siRNA or Gapdh-
targeting Accell siRNA. In general, PCKS maintained their
structural integrity after 48 h of incubation as well, with no
differences between the treatment groups, though minor signs
of cellular damage (e.g., cellular swelling and nuclear
dissolution) were observed in proximal tubules.
Spontaneous Inﬂammation in Untransfected PCTS
qPCR analyses were also performed to determine
whether spontaneous inﬂammation occurred in untransfected
PCLuS and PCKS (Fig. 5). To that end, mRNA expression of
Il1b, Il6, and Tnfa was studied over time (0, 24, and 48 h). In
PCLuS, mRNA expression of these pro-inﬂammatory cyto-
kines was found to signiﬁcantly increase over time. Tnfa
mRNA expression in PCKS had a similar pattern as in
PCLuS. However, in PCKS, different patterns were observed
in Il1b and Il6 mRNA expression as it signiﬁcantly increased
during the ﬁrst 24 h of culturing, after which it appeared to
decrease again.
Pro-inﬂammatory Cytokines in Transfected PCTS
The impact of Accell siRNA on the mRNA expression of
pro-inﬂammatory cytokines in PCLuS and PCKS was studied
by qPCR as well (Fig. 6). After 24 h, non-targeting Accell
siRNA and Gapdh-targeting Accell siRNA signiﬁcantly
decreased the mRNA expression of Il1b and Tnfa in PCLuS
by approximately 50%, as compared to untransfected slices.
Additionally, in comparison to untransfected PCLuS, PCLuS
treated with non-targeting Accell siRNA had a signiﬁcantly
lower (~ 50%) Il6 mRNA expression after 48 h. In contrast,
non-targeting Accell siRNA and Gapdh-targeting Accell
siRNA did not signiﬁcantly affect mRNA expression of pro-
inﬂammatory cytokines in PCKS after an incubation up to
48 h.
DISCUSSION
In this study, we set out to explore whether RNAi could
be achieved in PCLuS and PCKS from mouse tissue. It was
found that both PCLuS and PCKS were successfully
transfected with Gapdh-targeting Accell siRNA. This resulted
in signiﬁcant silencing of Gapdh mRNA expression, without
affecting the viability, and with limited effects on
inﬂammation.
Slice Transfection
To induce RNAi in PCTS, diffusion of Accell siRNA into
slices is required. In this study, it was demonstrated that
ﬂuorescent Accell siRNA diffused into PCLuS and PCKS,
though the extent of diffusion was greater in PCLuS.
Thereafter, we showed that RNAi was successfully induced
in PCLuS and PCKS with Accell siRNA as signiﬁcantly lower
Gapdh mRNA expression was observed in slices treated with
Gapdh-targeting Accell siRNA. Non-targeting Accell siRNA
did not induce signiﬁcant changes in Gapdh mRNA expres-
sion, suggesting no off-target effects. Preliminary experiments
showed lower siRNA concentrations did not result in Gapdh
mRNA silencing, whereas higher concentrations induced off-
target effects (data not shown). A previous publication on
polyplex-mediated siRNA transfections in PCTS prepared
from tumor xenografts (solid tissue) described similar mRNA
silencing (~ 50% after 96 h of incubation with 1 μM siRNA)
but then for Birc5 mRNA [12]. However, their transfection
technique cannot be compared to the technique presented
here (siRNA polyplexes vs. self-deliverable siRNA) as
different target mRNAs (Birc5 vs. Gapdh) and different
tissue types (tumor tissue vs. primary tissue) were used. We
Fig. 3. ATP content during siRNA transfections. a PCLuS and b PCKS were untransfected or treated with
non-targeting Accell siRNA or Gapdh-targeting Accell siRNA for 24 and 48 h (n = 4), after which the ATP
content was determined. Values (relative to untransfected slices, which are set to 1.0, at 24 and 48 h)
represent individual experiments performed in triplicate and are accompanied with the arithmetic mean
(horizontal line) ± standard error of the mean (error bars). No signiﬁcant differences were observed (one-
way ANOVA, post hoc Tukey’s multiple comparisons test)
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also attempted to transfect PCTS with Lipofectamine
RNAiMAX, which is a commonly used lipid transfection
reagent to transfect continuous cell lines, but we did not
observe any mRNA silencing (data not shown). However,
such reagents have a limited transfection efﬁciency in primary
cells [18]. As PCTS contain primary cells, it may have been
the case that lipoplexes were unable to be taken up via
endocytosis or to diffuse into PCTS. Accell siRNA does not
depend on endocytosis and, consequently, can lead to RNAi
in PCTS. In this present study, however, it appears a
transfection was achieved in the majority of cells that are
present in the slices, though further research is necessary to
obtain direct evidence. To that end, immunohistochemistry
could be used to identify if the transfection with siRNA was
uniform. In addition, by using a double-staining for cell-
speciﬁc markers, immunohistochemistry could be used to
show which cells are affected by the siRNA [19]. As GAPDH
is an intracellular house-keeping enzyme, further research on
speciﬁc cell-matrix and cell-cell interactions was beyond the
scope of this study, though such interactions could be assessed
in future studies with, for instance, in situ polymerase chain
reaction (PCR) [20].
Interestingly, differences were observed in Gapdh
mRNA silencing and siRNA penetration between PCLuS
and PCKS. PCKS required a higher concentration of Accell
siRNA than PCLuS to produce mRNA silencing effects (1 vs.
0.5 μM). This might be caused by differences in the number
of cells and the number of cells per unit volume. PCKS are
prepared from solid tissue, whereas PCLuS are prepared
from non-solid lung tissue inﬂated with agarose, which
accounts for a large volume in slices. As a result, PCKS
contain more cells than PCLuS [5]. Furthermore, the greater
number of cells per unit volume in PCKS might have also
affected the penetration of Accell siRNA by restraining the
diffusion of siRNA from a region of high concentration to a
region of low concentration. Researchers have previously
shown that ﬂuorescent lysozyme (~ 15 kDa) diffused into
PCKS prepared from mice [21,22]. As such, it is not surprising
that Accell siRNA, which has a comparable molecular weight
to the ﬂuorescent lysozyme, could also diffuse into PCKS.
Unlike PCKS, PCLuS contained an agarose matrix with a
pore size that enabled rapid diffusion of Accell siRNA,
thereby resulting in a higher mRNA silencing. Though there
are differences in the penetration of Accell siRNA between
PCLuS and PCKS, it remains striking that 55% Gapdh
mRNA silencing in PCLuS requires 0.5 μM Accell siRNA,
whereas only 40% Gapdh mRNA silencing in PCKS requires
1.0 μM Accell siRNA. This suggests that the outermost cells
in PCKS were more extensively transfected than the outer-
most cells in PCLuS. Nonetheless, the precise cellular and
intracellular localization of Accell siRNA remains largely
unclear and should be addressed in future research.
However, in neither PCLuS nor PCKS was GAPDH
protein expression affected by Gapdh-targeting Accell siRNA
Fig. 4. Morphology after siRNA transfections. Slices were untransfected (a PCLuS, b PCKS) or treated
with non-targeting Accell siRNA (c PCLuS, d PCKS) orGapdh-targeting Accell siRNA (e PCLuS, f PCKS)
for 48 h (n = 4). Thereafter, slices were collected for morphological analysis. Parafﬁn sections (4 μm) were
stained with H&E and subsequently scanned. Representative images (magniﬁcation 20×) are shown of
independent experiments performed in triplicate
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after 48 h of incubation, as determined by Western blotting
(data not shown). The discrepancy between Gapdh mRNA
expression and GAPDH protein expression could have arisen
from differences in their intracellular half-lives. The half-life
Fig. 6. Pro-inﬂammatory cytokines in transfected PCTS. PCLuS and PCKS were untransfected or treated with non-targeting Accell siRNA or
Gapdh-targeting Accell siRNA for 24 and 48 h (n = 4). Afterwards, the mRNA expression of Il1b (a PCLuS, d PCKS), Il6 (b PCLuS, e PCKS),
and Tnfa (c PCLuS, f PCKS) was analyzed by qPCR. 18s was used as reference gene. Values (relative to untransfected slices, which are set to
1.0, at 24 and 48 h) represent individual experiments performed in triplicate and are accompanied with the arithmetic mean (horizontal line) ±
standard error of the mean (error bars). Differences were statistically signiﬁcant when p < .05 (one-way ANOVA, post hoc Tukey’s multiple
comparisons test)
Fig. 5. Spontaneous inﬂammation in untransfected PCTS. Untransfected PCLuS and PCKS were sampled directly after slicing (0 h) and after
an incubation of 24 or 48 h (n = 3–4). Thereafter, mRNA expression of Il1b (a PCLuS, d PCKS), Il6 (b PCLuS, e PCKS), and Tnfa (c PCLuS, f
PCKS) was analyzed by qPCR. 18s was used as reference gene. Values represent individual experiments performed in triplicate and are
accompanied with the arithmetic mean (horizontal line) ± standard error of the mean (error bars). Differences were statistically signiﬁcant
when p < .05 (one-way ANOVA, post hoc Tukey’s multiple comparisons test)
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of Gapdh mRNA in HeLa cells has been previously
demonstrated to be ~ 8 h, whereas the half-lives of GAPDH
protein in NRK-52E and A549 cells have been shown to be
greater than 35 h [23–25]. This could mean that equilibration
between Gapdh mRNA and protein levels requires more
time because reductions in mRNA do not directly affect
protein concentrations. Thus, it is worthwhile to select
proteins with a quick turn-over or to extend the incubation
time to allow for equilibration between mRNA and protein.
However, extending the incubation time would require the
optimization of incubation conditions in order to prevent
myoﬁbroblast overgrowth in PCLuS and to prevent apoptosis
of the proximal tubules in PCKS.
Slice Viability
The effects of Accell siRNA on the viability of PCLuS and
PCKS was studied from a biochemical and morphological
perspective. In both PCLuS and PCKS, no signiﬁcant differences
in ATP content were observed between untransfected slices and
slices treated with non-targeting Accell siRNA and Gapdh-
targeting Accell siRNA. This indicates that the viability of slices
was not affected. These results are in line with the morphology of
the slices. PCLuSmaintained all morphological features after 48 h
of incubation.However, both untransfected and transfected PCKS
contained some apoptotic proximal tubules (marked by loss of
nuclei and swelling of cells), although the general morphology
remained unaffected. Apoptosis in proximal tubules has been
reported previously, and the authors suggested it is caused by a
disturbed pre-urine ﬂow [8,22]. As such, observed morphological
changes in PCKS are not attributable to the siRNA.
Slice Inﬂammation
We also showed that spontaneous inﬂammation devel-
oped in untransfected PCLuS and PCKS, as marked by a
signiﬁcant increase in mRNA expression of pro-inﬂammatory
markers Il1b, Il6, and Tnfa during incubation [16]. Con-
versely, in PCKS, mRNA expression of Il1b and Il6 appeared
to decrease after 24 h, suggesting partial resolution. None-
theless, cytokine production in PCTS is usually not as
pronounced as immune responses in vivo because immune
cells cannot be recruited from the blood [26]. As such, the
extent of immune responses in PCTS is dependent on the
number and type of immune cells in the tissue slice. The root-
cause of this inﬂammatory response in slices is not fully
understood, though it probably results from mechanical (e.g.,
slicing procedure itself) and chemical injury (e.g., warm/cold
ischemia) which can lead to a wound-repair response [27].
Previous literature reported similar responses in precision-cut
intestinal slices (PCIS) prepared from rat, mouse, and human
tissue [28]. Furthermore, PCKS prepared from human tissue
have also been characterized by inﬂammation upon incuba-
tion for up to 48 h [8].
We also studied whether Accell siRNA had an effect on
the spontaneous inﬂammation in PCLuS and PCKS. In
general, unmodiﬁed siRNA can activate the innate immune
system via siRNA sequence-dependent or sequence-
independent recognition by pattern recognition receptors
(PRR) such as toll-like receptors (TLR) 3, 7, and 8; protein
kinase R (PKR); and retinoic-inducible gene 1 (RIG-1) [16].
Activation of these receptors sets off an immune signaling
cascade which leads to an inﬂammatory response character-
ized by an increased mRNA expression of pro-inﬂammatory
cytokines Il1b, Il6, and Tnfa. Interestingly, non-targeting and
Gapdh-targeting Accell siRNA appeared to diminish sponta-
neous inﬂammation in PCLuS as demonstrated by decreases
in Il1b (at 24 h), Il6 (at 48 h), and Tnfa (at 24 h) mRNA
expression. These effects were observed in PCLuS but not in
PCKS. This could perhaps be caused by differences in the
amount and type of immune cells present in both tissue types,
as mentioned previously [6]. As these reductions are similar
between non-targeting and Gapdh-targeting Accell siRNA,
we hypothesize that Accell siRNA acts as an antagonist on
siRNA sequence-independent proteins PKR and RIG-1,
which are both present in the cytoplasm. It could be that
the sterol modiﬁcation on Accell siRNA inhibits the activa-
tion of PKR and RIG-1 through steric hindrance and, as a
result, prevent activation of an immune signaling cascade.
Nevertheless, the exact cause of immunosuppressive effects
remains the subject of speculation. Further analysis was
beyond the scope of this study.
CONCLUSION
In this study, we have demonstrated that PCLuS and
PCKS can be successfully transfected with Accell siRNA to
induce RNAi. Signiﬁcant mRNA silencing was achieved
without compromising the viability and structural integrity
of the slices. Moreover, Accell siRNA did not induce an
inﬂammatory response in either PCLuS or PCKS. As such,
this ex vivo transfection model, which combines advantages of
in vitro and in vivo models (e.g., simplicity, ﬂexibility,
throughput, and representability), could be used to decrease
the expression of disease-related genes, to investigate the
function of proteins, or to establish experimental models of
disease in PCTS. Furthermore, PCTS can be prepared from
human tissue which makes this transfection model particu-
larly useful in translational research.
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